Provided by Tiger Trade Technology Pte. Ltd.

Alnylam Pharmaceuticals

241.20
+0.51000.21%
Volume:107.68K
Turnover:25.86M
Market Cap:32.18B
PE:42.92
High:243.03
Open:242.40
Low:238.02
Close:240.69
52wk High:495.55
52wk Low:197.81
Shares:133.43M
Float Shares:133.16M
Volume Ratio:0.57
T/O Rate:0.08%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.62
EPS(LYR):2.33
ROE:96.55%
ROA:12.34%
PB:23.77
PE(LYR):103.52

Loading ...

Does Alnylam’s Generative AI Pact With Inceptive Nucleics Redraw The R&D Bull Case For ALNY?

Simply Wall St.
·
Jun 16

Alnylam to host 10th RNAi Roundtable webcast series on pipeline updates

Reuters
·
Jun 12

Alnylam, Genesis Pharma Expand Commercial Partnership Into 4 Nordic Markets

MT Newswires Live
·
Jun 10

Genesis Pharma: Extended Agreement With Alnylam Pharmaceuticals NOW Includes Denmark, Finland, Norway, and Sweden

THOMSON REUTERS
·
Jun 10

Genesis Pharma Expands Strategic Commercial Partnership With Alnylam Pharmaceuticals for Rnai Therapeutics to Nordic Region

THOMSON REUTERS
·
Jun 10

Alnylam expands GENESIS Pharma commercialization partnership to Nordic markets

Reuters
·
Jun 10

Bloom Energy, Astera Labs, Alnylam, Reddit Could Be Among Next Adds to S&P 500

Dow Jones
·
Jun 09

BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EDT on 2026-06-08

Reuters
·
Jun 08

Alnylam Pharmaceuticals Price Target Maintained With a $510.00/Share by HC Wainwright & Co.

Dow Jones
·
Jun 05

Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY) and Fractyl Health, Inc. (GUTS)

TIPRANKS
·
Jun 05

BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EDT on 2026-06-04

Reuters
·
Jun 04

Alnylam And Inceptive Form Strategic AI Collaboration To Accelerate Discovery Of RNAi Therapeutics

Reuters
·
Jun 04

Alnylam Commits Up to $2B to AI-Driven Therapeutic Innovation -- Company Talk

Dow Jones
·
Jun 04

Alnylam Collaboration Aims to Accelerate Timelines For Drug Discovery -- Company Talk

Dow Jones
·
Jun 04

Alnylam, Inceptive form strategic AI collaboration

TIPRANKS
·
Jun 04

Alnylam partners with Inceptive in AI-driven RNAi drug discovery deal worth up to $2 billion

Reuters
·
Jun 04

Alnylam Pharmaceuticals - Co and Inceptive Collaboration Valued at up to $2 Bln With $30 Mln Upfront

THOMSON REUTERS
·
Jun 04

Alnylam and Inceptive Form Strategic AI Collaboration to Accelerate the Discovery of Rnai Therapeutics

THOMSON REUTERS
·
Jun 04

Alnylam director David E.I. Pyott disposes of USD 1.14 million in common shares

Reuters
·
Jun 04

Alnylam files Form 3 for director Benjamin Cravatt

Reuters
·
Jun 04